The Real-world Evidence Analytics Market is expected to grow at a CAGR of 15.1% during the forecast period 2022–2029 to reach $2.93 billion by 2029. Real-World Evidence (RWE) is reshaping the landscape of healthcare by utilizing clinical evidence obtained from Real-World Data (RWD) analysis. This powerful approach evaluates the benefits and risks associated with...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian